Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity.

Source:http://linkedlifedata.com/resource/pubmed/id/16309911

Bioorg. Med. Chem. 2006 Apr 1 14 7 2089-108

Download in:

View as

General Info

PMID
16309911